Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
      • División de Aviación
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Recovery Resources
    • Ley de Libertad de Información
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Recovery Resources
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2023 (35)
  • 2022 (52)
  • 2021 (52)
  • 2020 (42)
  • 2019 (50)
  • 2018 (56)
  • 2017 (46)
  • 2016 (34)
  • 2015 (28)
  • 2014 (41)
  • 2013 (64)
  • 2012 (20)
  • 2011 (71)

Subject

Drug Name

Field Division

  • New England (270)
  • San Francisco (152)
  • New York (150)
  • Seattle (126)
  • Houston (124)
  • Miami (110)
  • Atlanta (105)
  • St. Louis (99)
  • Detroit (84)
  • Chicago (77)
  • New Orleans (71)
  • Washington, DC (67)
  • New Jersey (62)
  • Los Angeles (58)
  • Philadelphia (50)
  • El Paso (47)
  • Caribe (38)
  • Rocky Mountain (33)
  • San Diego (29)
  • Dallas (25)
  • Omaha (6)
  • Louisville (5)
  • Phoenix (56)
  • Sede (48)
Clear All Results

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

Diciembre 23, 2015
WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...

DEA Announces “360 Strategy” To Address Heroin, Prescription Drugs And Violent Crime

Noviembre 10, 2015
PITTSBURGH - The United States Drug Enforcement Administration today announced Pittsburgh as the pilot city for a comprehensive law enforcement and prevention “360 Strategy” to help cities dealing with a heroin and prescription drug abuse epidemic, and its associated violent crime. DEA Special Agent in Charge for the Philadelphia Division...

DEA Executes Warrants On Arizona Reservation

Noviembre 05, 2015
PHOENIX - Drug Enforcement (DEA) Special Agent in Charge Doug Coleman announced today the execution of over 15 arrest warrants stemming from a federal grand jury indictment of a predominantly female methamphetamine trafficking organization operating in the Colorado River Indian Reservation. Two other subjects were in custody at the time...

DEA Releases 2015 Drug Threat Assessment: Heroin And Painkiller Abuse Continue To Spike

Noviembre 05, 2015
PHOENIX - DEA today announced results from the 2015 National Drug Threat (NDTA), which finds that drug overdose deaths are the leading cause of injury death in the United States, ahead of motor vehicle deaths and firearms. In 2013, over 46,000 people in the United States died from drug overdose...

DEA Releases 2015 Drug Threat Assessment: Heroin And Painkiller Abuse Continue To Concern

Noviembre 04, 2015
WASHINGTON - DEA Acting Administrator Chuck Rosenberg today announced results from the 2015 National Drug Threat (NDTA), which found that drug overdose deaths are the leading cause of injury death in the United States, ahead of deaths from motor vehicle accidents and firearms. In 2013, more than 46,000 people in...

DEA Investigation Leads To Million-Dollar Fine

Octubre 29, 2015
PHOENIX - DEA announced today, the results of an investigation of an Allentown, PA, based chemical company, who pleaded guilty to six charges including failing to report the disappearance of shipments of (MMA), a precursor for the manufacture of methamphetamine. Taminco US, Inc. (“Taminco”) has also reached a settlement with...

151 Arrested In DEA-Led Investigation Of Synthetic Drug Rings

Octubre 15, 2015
WASHINGTON - The Drug Enforcement (DEA), Immigration and Customs (ICE) Homeland Security (HSI), Customs and Border (CBP), along with other federal, state, and local law enforcement today concluded a 15-month, nationwide drug interdiction effort that resulted in 151 arrests in 16 states. The enforcement action, known as Project Synergy III...

Arizonans Turn In 5 Tons Of Prescription Drugs To DEA

Octubre 02, 2015
PHOENIX - The Drug Enforcement (DEA) finalized the collection and tally of prescription drugs turned in this past Saturday by citizens across Arizona in conjunction with DEA’s National Prescription Drug Take Back Day. In all, over 10,601 pounds of controlled substances were removed from homes throughout the state in a...

DEA’S Prescription Drug Take-Back Effort-- A Big Success

Octubre 01, 2015
WASHINGTON - Thousands of Americans in communities across the country discarded more than 350 tons of unused, expired, or unwanted drugs as part of the Drug Enforcement Administration’(DEA) National Prescription Drug Take-Back Day (NTBI) on Saturday, September 26. This past weekend, more than 3,800 federal, state and local counterparts took...

DEA Dialogues With Registrants On Preventing Pharmaceutical Diversion At Conference This Week

Septiembre 25, 2015
WASHINGTON - The new head of the U.S. Drug Enforcement Administration’(DEA’s) Office of Diversion Control met with the agency’s registered pharmaceutical manufacturers, importers, and exporters this week to discuss how they can prevent pharmaceutical diversion while minimizing the impact on legitimate commerce. Almost 300 registrants attended the conference held September...
Showing 1 - 10 of 99 results

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Programa de Asistencia al Empleado
    • Empleador con Igualdad de Oportunidades
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Hacer Negocios
    con la DEA
    • Resumen
    • Proveedores Actuales
    • Futuros Vendedores
    • Cláusulas de Seguridad
    • Formularios de Seguridad
    • Programa de Pequeñas Empresas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster